Dr. Danny Fox, M.D

NPI: 1568416816
Total Payments
$3,498
2023 Payments
$38.39
Companies
23
Transactions
266
Medicare Patients
3,223
Medicare Billing
$245,595

Payment Breakdown by Category

Food & Beverage$3,360 (96.0%)
Other$95.00 (2.7%)
Education$43.29 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,360 261 96.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $95.00 1 2.7%
Education $43.29 4 1.2%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $430.95 82 $0 (2020)
AstraZeneca Pharmaceuticals LP $422.81 30 $0 (2020)
Novo Nordisk Inc $382.79 23 $0 (2022)
Merck Sharp & Dohme Corporation $328.15 25 $0 (2020)
Allergan Inc. $301.95 12 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $276.82 16 $0 (2020)
Takeda Pharmaceuticals U.S.A., Inc. $207.17 13 $0 (2022)
Lilly USA, LLC $192.85 13 $0 (2019)
Amgen Inc. $186.93 12 $0 (2019)
SANOFI-AVENTIS U.S. LLC $168.00 5 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $38.39 2 ABBVIE INC. ($22.09)
2022 $217.45 12 Takeda Pharmaceuticals U.S.A., Inc. ($156.24)
2020 $288.62 16 Novo Nordisk Inc ($59.23)
2019 $1,056 76 Novo Nordisk Inc ($220.92)
2018 $879.55 79 Boehringer Ingelheim Pharmaceuticals, Inc. ($134.93)
2017 $1,018 81 Allergan Inc. ($211.87)

All Payment Transactions

266 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
05/18/2023 GlaxoSmithKline, LLC. AREXVY (Drug), SHINGRIX Food and Beverage In-kind items and services $16.30 General
Category: RESPIRATORY
03/01/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $22.09 General
Category: NEUROSCIENCE
11/07/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $7.81 General
Category: NEUROSCIENCE
11/07/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $0.86 General
Category: NEUROSCIENCE
10/26/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $25.70 General
Category: NEUROSCIENCE
09/09/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $24.68 General
Category: NEUROSCIENCE
08/08/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.58 General
Category: NEUROSCIENCE
08/04/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.66 General
Category: Diabetes
07/01/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $25.61 General
Category: NEUROSCIENCE
06/15/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $20.11 General
Category: NEUROSCIENCE
02/17/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $17.59 General
Category: NEUROSCIENCE
02/10/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.85 General
Category: Diabetes
01/27/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $20.78 General
Category: NEUROSCIENCE
01/04/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $24.22 General
Category: NEUROSCIENCE
03/12/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.91 General
Category: GASTROENTEROLOGY
03/10/2020 Novo Nordisk Inc Food and Beverage In-kind items and services $15.55 General
02/25/2020 PFIZER INC. PREVNAR 13 (Biological) Food and Beverage In-kind items and services $13.01 General
Category: VACCINES
02/21/2020 PFIZER INC. COLOGUARD (Device) Food and Beverage In-kind items and services $13.69 General
Category: GASTROINTESTINAL
02/20/2020 PFIZER INC. CHANTIX (Drug), COLOGUARD Food and Beverage In-kind items and services $13.45 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
02/13/2020 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $21.03 General
Category: NEUROSCIENCE
02/11/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS, Tresiba Food and Beverage In-kind items and services $24.75 General
Category: Diabetes
02/06/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.69 General
Category: Cardiovascular and Metabolism
01/30/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.39 General
Category: Cardiovascular and Metabolism
01/28/2020 Merck Sharp & Dohme Corporation PNEUMOVAX 23 (Biological), GARDASIL 9 Food and Beverage In-kind items and services $17.63 General
Category: VACCINE
01/23/2020 Astellas Pharma US Inc MYRBETRIQ (Drug) Food and Beverage In-kind items and services $23.53 General
Category: UROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 875 1,011 $206,514 $67,177
2022 14 865 999 $210,149 $66,830
2021 14 671 807 $184,741 $58,281
2020 12 812 969 $166,608 $53,308
Total Patients
3,223
Total Services
3,786
Medicare Billing
$245,595
Procedure Codes
55

All Medicare Procedures & Services

55 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 172 283 $87,940 $24,111 27.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 132 132 $41,420 $16,596 40.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 72 93 $20,509 $5,765 28.1%
99497 Advance care planning, first 30 minutes Office 2023 101 101 $20,563 $5,674 27.6%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 13 13 $8,320 $3,390 40.7%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 131 131 $5,903 $2,319 39.3%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 119 119 $5,355 $2,106 39.3%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 11 11 $4,433 $1,780 40.2%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 11 11 $4,433 $1,777 40.1%
90662 Influenza vaccine split virus, preservative free Office 2023 23 23 $2,415 $1,579 65.4%
G0008 Administration of influenza virus vaccine Office 2023 24 24 $1,145 $695.52 60.7%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 13 16 $2,000 $604.80 30.2%
G0009 Administration of pneumococcal vaccine Office 2023 15 15 $713.00 $423.36 59.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 27 28 $980.00 $240.94 24.6%
G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report Office 2023 11 11 $385.00 $115.19 29.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 168 282 $90,240 $23,769 26.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 130 130 $42,380 $16,749 39.5%
99497 Advance care planning, first 30 minutes Office 2022 113 113 $24,069 $6,218 25.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 57 71 $16,117 $4,465 27.7%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 14 14 $8,960 $3,891 43.4%
G0442 Annual alcohol misuse screening, 15 minutes Office 2022 141 141 $6,486 $2,565 39.5%
G0444 Annual depression screening, 15 minutes Office 2022 127 127 $5,715 $2,271 39.7%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 12 12 $5,028 $1,981 39.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 11 11 $4,609 $1,814 39.4%
90662 Influenza vaccine split virus, preservative free Office 2022 16 16 $1,680 $1,097 65.3%

About Dr. Danny Fox, M.D

Dr. Danny Fox, M.D is a Family Medicine healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568416816.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Fox, M.D has received a total of $3,498 in payments from pharmaceutical and medical device companies, with $38.39 received in 2023. These payments were reported across 266 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,360).

As a Medicare-enrolled provider, Fox has provided services to 3,223 Medicare beneficiaries, totaling 3,786 services with total Medicare billing of $245,595. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Oldsmar, FL
  • Active Since 05/20/2006
  • Last Updated 08/15/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1568416816

Products in Payments

  • FARXIGA (Drug) $320.68
  • JANUVIA (Drug) $179.61
  • TRINTELLIX (Drug) $156.24
  • NAMENDA XR (Drug) $139.42
  • Ozempic (Drug) $133.99
  • SOLIQUA (Drug) $132.49
  • JARDIANCE (Drug) $124.25
  • CHANTIX (Drug) $111.01
  • Tresiba (Drug) $102.56
  • Prolia (Biological) $98.10
  • LYRICA (Drug) $94.99
  • INVOKANA (Drug) $91.53
  • XIFAXAN (Drug) $91.08
  • ELIQUIS (Drug) $89.71
  • TRULICITY (Drug) $77.98
  • SYMBICORT (Drug) $71.32
  • BASAGLAR (Drug) $70.90
  • PREVNAR - 13 (Biological) $66.21
  • TRADJENTA (Drug) $65.32
  • ZOSTAVAX (Biological) $64.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Oldsmar